Corrigendum
Split Viewer
Mol. Cells 2022; 45(10): 761-761
Published online October 6, 2022
https://doi.org/10.14348/molcells.2022.0009.e
© The Korean Society for Molecular and Cellular Biology
Corrigendum to: Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells
Correspondence to : jhoonkim@kribb.re.kr (JHK); jungaekim@kribb.re.kr (JAK)
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.
Body
Corrigendum to: Mol. Cells 2022; 45(8): 550-563
https://doi.org/10.14348/molcells.2022.0009
In the ACKNOWLEDGMENTS section of the above article, the incorrect grant number should be revised as written below. The correct grant number is underlined.
ACKNOWLEDGMENTS
This work was supported by a grant (NRF-2019R1A2C108615114 to J.-A.K.) from the National Research Foundation, Ministry of Science and ICT and Future Planning and by the Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program (171134054 to J.-A.K. and KGM99922111 to J.-H.K. [Jeong-Hoon Kim] and J.-A.K.).
The online version of the original article can be found under Mol. Cells 2022; 45(8): 550-563.
PDF
Standard view
Export citation
Share Article
Corrigendum
Mol. Cells 2022; 45(10): 761-761
Published online October 31, 2022 https://doi.org/10.14348/molcells.2022.0009.e
Copyright © The Korean Society for Molecular and Cellular Biology.
Corrigendum to: Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells
Mijin Park1,2, Byul Moon1,2, Jong-Hwan Kim3, Seung-Jin Park1,2, Seon-Kyu Kim1,2, Kihyun Park4, Jaehoon Kim4, Seon-Young Kim1,3, Jeong-Hoon Kim1,5,*, and Jung-Ae Kim1,2,*
1Department of Functional Genomics, Korea Research Institute of Bioscience and Biotechnology (KRIBB) School of Bioscience, University of Science and Technology, Daejeon 34113, Korea, 2Personalized Genomic Medicine Research Center, KRIBB, Daejeon 34141, Korea, 3Korea Bioinformation Center, KRIBB, Daejeon 34141, Korea, 4Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea, 5Disease Target Structure Research Center, KRIBB, Daejeon 34141, Korea
Correspondence to:jhoonkim@kribb.re.kr (JHK); jungaekim@kribb.re.kr (JAK)
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.
Body
Corrigendum to: Mol. Cells 2022; 45(8): 550-563
https://doi.org/10.14348/molcells.2022.0009
In the ACKNOWLEDGMENTS section of the above article, the incorrect grant number should be revised as written below. The correct grant number is underlined.
ACKNOWLEDGMENTS
This work was supported by a grant (NRF-2019R1A2C108615114 to J.-A.K.) from the National Research Foundation, Ministry of Science and ICT and Future Planning and by the Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program (171134054 to J.-A.K. and KGM99922111 to J.-H.K. [Jeong-Hoon Kim] and J.-A.K.).
The online version of the original article can be found under Mol. Cells 2022; 45(8): 550-563.
Previous Article
